Safety, Tolerability and Pharmacokinetics of Y-2(Edaravone And Borneol) Sublingual Tablet
Clinical trial NCT03495206 · UNKNOWN
Trial details
- NCT number
- NCT03495206
- Sponsor
- Yantai YenePharma Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-25
- Primary completion
- 2020-12-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.